Programmable transdermal drug delivery

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$748,768.00
Award Year:
2010
Program:
SBIR
Phase:
Phase II
Contract:
2R44AR055837-02
Agency Tracking Number:
AR055837
Solicitation Year:
2010
Solicitation Topic Code:
NIAMS
Solicitation Number:
PHS2010-2
Small Business Information
LOS GATOS RESEARCH
LOS GATOS RESEARCH, 67 E EVELYN AVE, STE 3, MOUNTAIN VIEW, CA, -
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
928805761
Principal Investigator:
MICAH YAIRI
(650) 965-7841
M.YAIRI@LGRINC.COM
Business Contact:
MICAH YAIRI
(650) 965-7772
d.baer@lgrinc.com
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Prostate cancer and central precocious puberty - linked through improper gonadal steroid levels - are most common in either the elderly or youth populations. Similar gonadal steroid problems also connected to endometriosis. Some traditional methodologies for treating these illnesses involves daily injections of medicine, which can become painful or be forgotten, result in under-dosing. Los Gatos Research is developing an alternative method for delivering time-controlled drug formulations that is practically pain free. Furthermore, the novel technology provides an extended, programmable release platform that helps patients avoid the need to remember to take medication (particularly important for portions of the elderly population) and offers the potential to use less medicine to produce the same effect due to the ability to customize the delivery to the individual patient. The technologies developed in this proposed project enable programmable, microfluidic transdermal patches to provide a means for delivering large molecular weight drug formulations that is controlled, painless, and direct. The specific aims of the Phase II project include upgrading the unique programmable transdermal patches, testing and validating their performance capabilities, optimizing them for rapid, controlled delivery of medication to control gonadal steroid levels, and conducting initial pre- clinical trials of the patches.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government